Analysis of Physicochemical Properties and Mechanisms of Action of Analgesic Drugs: A Focus on Opioid and Non-Opioid Pathways
DOI:
https://doi.org/10.54097/2py9qm33Keywords:
Analgesic drugs, Oxycodone, Opioid receptors, Pharmacokinetics, NSAIDs.Abstract
One of the most difficult and significant aspects in clinical pharmacology is the issue of pain management. Opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and adjuvant analgesics are a large group of drugs that have various physical and chemical characteristics that influence their pharmacokinetic activity and pharmacodynamic response. This paper is an extensive overview of the structural features, physicochemical data (such as lipophilicity, pKa, protein binding, and permeability of the blood-brain barrier), and molecular action of some examples of analgesic agents. Special attention has been given to the opioid subgroup, where the example of oxycodone was used as a model case study in which minor structural changes, namely the 3-methoxy group and 14-hydroxy substitution, resulted in different metabolic pathways (CYP3A4- and CYP2D6-mediated), greater oral bioavailability, and unique kinetics of receptor-binding when compared to morphine. In addition to the discussion of non-opioid analgesics such as COX inhibitors and voltage-gated ion channel modulators, the structure-activity relationships are discussed. Moreover, the effects of drug-drug interactions on analgesic therapy of analgesia, pharmacogenetics (e.g., poor metabolizer phenotypes of CYP2D6), and new approaches to the optimization of analgesic treatment were also considered. This compilation will be helpful in providing a structured source of information about how therapeutic effects are determined by the properties of physicochemical properties and what should be done next to develop drugs.
Downloads
References
[1] World Health Organization. Global Pain Management Report 2023. Geneva: WHO Press; 2024.
[2] Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med. 1998; 104(3): 2S-8S. DOI: https://doi.org/10.1016/S0002-9343(97)00203-9
[3] Pasternak GW. Molecular biology of opioid analgesia. Annu Rev Pharmacol Toxicol. 2014; 54: 1-20.
[4] McQuay HJ, Moore RA. Opioid pharmacokinetics. Clin Pharmacokinet. 1984; 9(2): 115-132.
[5] Manglik A, Kruse AC, Kobilka TS, et al. The μ-opioid receptor in a crystal form with morphinan antagonist. Nature. 2012; 485(7398): 321-326. DOI: https://doi.org/10.1038/nature10954
[6] Lötsch J, Geisslinger G, Tegeder I. Pharmacogenetics of opioid analgesics. Clin Pharmacol Ther. 2009; 85(6): 622-626.
[7] Smith HS. Opioid metabolism. Pain Physician. 2008; 11(2 Suppl). DOI: https://doi.org/10.36076/ppj.2008/11/S1
[8] Pöyhiä R, Seppälä T. Oxycodone: pharmacokinetics and pharmacodynamics. Eur J Pain. 2008; 12(4): 407-415.
[9] Samer CF, Daali Y, Wagner M, et al. Genetic polymorphism and drug interactions that regulate CYP2D6 and CYP3A4 activities. Clin Pharmacokinet. 2013; 52(9): 773-792.
[10] Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011; 115(6): 1363-1381. DOI: https://doi.org/10.1097/ALN.0b013e318238bba6
[11] Lemberg KK, Kontinen VK, Siiskonen AO, et al. Antinociceptive properties of oxycodone in neuropathic pain. Eur J Pain. 2006; 10(8): 711-721.
[12] Stein C, Machelska H. Peripheral opioid analgesia: mechanisms and clinical implications. Curr Opin Pharmacol. 2011; 11(1): 54-60.
[13] Grosser T, Smyth EM, FitzGerald GA. Anti-inflammatory, antipyretic and analgesic drugs. In: Brunton LL, ed. The Pharmacological Basis of Therapeutics by Goodman & Gilman. 13th ed. New York: McGraw-Hill; 2018.
[14] Taylor CP, Gee NS, Su TZ, et al. An overview of mechanistic theories of gabapentin pharmacology. Epilepsy Res. 1998; 29(3): 233-249. DOI: https://doi.org/10.1016/S0920-1211(97)00084-3
[15] Van Booven D, Marsh S, McLeod H, et al. Cytochrome P450 2C9 (CYP2C9) and 2C19 (CYP2C19) pharmacogenomics. Pharmacogenomics. 2004; 5(8): 1097-1108.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

